Company Filing History:
Years Active: 2018
Title: Zhenghui Xu: Innovator in Cell-Mediated Immune Response
Introduction
Zhenghui Xu is a prominent inventor based in Hainan, China. He has made significant contributions to the field of immunology, particularly in developing methods to enhance cell-mediated immune responses. His innovative approach has the potential to impact vaccine development and therapeutic strategies.
Latest Patents
Zhenghui Xu holds 1 patent for his invention titled "Methods and compositions for promoting a cell-mediated immune response." This patent describes a method for stimulating a cell-mediated immune response to an antigen by administering a target antigen alongside a transport factor derived from a bipartite protein exotoxin. The invention emphasizes the use of specific fragments of the lethal factor protein that enhance immune response without the protective antigen.
Career Highlights
Zhenghui Xu is associated with Vaccine Technologies, Incorporated, where he applies his expertise in immunology to advance vaccine technologies. His work focuses on developing innovative solutions to promote effective immune responses against various antigens, including viral and tumor antigens.
Collaborations
Zhenghui Xu collaborates with notable colleagues such as Yichen Lu and Nicholas Kushner. Their combined efforts contribute to the advancement of vaccine technologies and the exploration of new immunological methods.
Conclusion
Zhenghui Xu's contributions to the field of immunology through his innovative patent and work at Vaccine Technologies, Incorporated highlight his role as a key inventor in promoting cell-mediated immune responses. His research has the potential to lead to significant advancements in vaccine development and therapeutic applications.